OakChart

Nurix Therapeutics Inc

NRIXHealthcare·Biotechnology·USA·Small·NASD·Nov 11 • 3:59 PM ET

16.33+0.45 (2.83%)
2026-11-12 02:01 CET
Market cap
1,734.89 USD m
Revenue, TTM
701.94 USD m
Net income, TTM
294.88 USD m
Free cash flow, TTM
369.81 USD m
EPS diluted, TTM
2.31
P/E
7.06
Compare

Price

NRIX against its 20, 50 and 200-day averages
2050200beatmiss
15.0020.0025.0010.5M21.1MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26NRIXclose 16.3320-day 22.8350-day 23.67200-day 20.1516.3352w high

42.2% under the 52-week high of 28.23 on 19 Aug 2026. 52-week low 12.01 on 11 Nov 2025. Last 15 sessions, 89.4% high to low

Volume 1.28× normal · the line is the 50-bar volume average

Profile

NRIX
52-week range, 27% of the way up
12.0128.23

Nurix Therapeutics, Inc. is a clinical stage biopharmaceutical company. It engages in the business of discovering, developing, and commercializing innovative small molecules and antibody therapies based on the modulation of cellular protein levels as a novel treatment approach for cancer, inflammatory conditions, and other challenging diseases. The company was founded by John Kuriyan, Michael Rape, and Arthur Weiss in 2009 and is headquartered in Brisbane, CA.

IndexRUT
Employees317
IPOJul 24, 2020
Beta1.84
ATR, 14d1.66
Rel volume1.28
Short float18.20%
Insider own4.76%
Inst own104.36%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap1.78B
Enterprise Value801.12M
Income294.88M
Sales701.94M
Book/sh8.87
Cash/sh9.60
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees317
IPOJul 24, 2020

Ratios

P/E7.06
Forward P/E-
PEG-
P/S2.54
P/B1.84
P/C1.70
P/FCF4.82
EV/EBITDA2.62
EV/Sales1.14
Quick Ratio8.44
Current Ratio8.44
Debt/Eq0.07
LT Debt/Eq0.06
Option/ShortYes / Yes

Earnings

EPS (ttm)2.31
EPS next Y-2.14
EPS next Q-0.42
EPS this Y177.12%
EPS next Y-190.94%
EPS next 5Y31.84%
EPS past 3/5Y6.31% -2.04%
Sales past 3/5Y29.55% 36.35%
EPS Y/Y TTM184.54%
Sales Y/Y TTM738.76%
EPS Q/Q560.95%
Sales Q/Q8426.27%
EarningsOct 12 AMC
EPS/Sales Surpr.887.15% 2664.30%

Ownership

Insider Own4.76%
Insider Trans-3.07%
Inst Own104.36%
Inst Trans-7.06%
ROA34.33%
ROE43.99%
ROIC28.62%
Gross Margin97.74%
Oper. Margin41.27%
Profit Margin42.01%
SMA20-28.48%
SMA50-31.00%
SMA200-18.95%
Trades-

Technical

Shs Outstand109.20M
Shs Float104.05M
Short Float18.20%
Short Ratio8.15
Short Interest18.94M
52W High28.23 -42.15%
52W Low12.01 35.97%
Volatility7.47% 6.30%
ATR (14)1.66
RSI (14)28.56
Beta1.84
Rel Volume1.28
Avg Volume2.32M
Volume2,979,473

Performance

Perf Week2.38%
Perf Month-26.21%
Perf Quarter-39.94%
Perf Half Y0.93%
Perf YTD-13.92%
Perf Year26.98%
Perf 3Y209.87%
Perf 5Y-50.60%
Perf 10Y-
Recom1.21
Target Price33.50
Prev Close15.88
Price16.33
Change %2.83%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Jun 29, 2026ResumedOOppenheimerOutperform$28+71.5%
Jan 08, 2026UpgradeMMorgan StanleyEqual-Weight → Overweight$36+120.5%
Nov 24, 2025ResumedTTruistBuy$30+83.7%
Oct 21, 2025InitiatedMMizuhoOutperform$24+47.0%
Mar 17, 2025InitiatedLLeerink PartnersMarket Perform$16-2.0%
Dec 10, 2024InitiatedBBTIG ResearchBuy$35+114.3%
Dec 06, 2024InitiatedBBMO Capital MarketsOutperform$35+114.3%
Oct 24, 2024InitiatedUUBSBuy$35+114.3%
Oct 11, 2024InitiatedJJefferiesBuy$41+151.1%
Sep 06, 2024ResumedRRobert W. BairdOutperform$26+59.2%

Peers

Mkt cap
TickerCompanyMkt cap
KYMRKymera Therapeutics Inc11.51B
ARVNArvinas Inc452.51M
CCCCC4 Therapeutics Inc379.51M
GLUEMonte Rosa Therapeutics Inc880.99M
ONCBeOne Medicines Ltd ADR44.22B
LLYLilly(Eli) & Co1352.12B
ABBVAbbvie Inc521.41B
AZNAstrazeneca plc287.66B
BMYBristol-Myers Squibb Co128.59B
SNYSanofi ADR115.43B

Insider trading

latest 14 of 88
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
van Houte HansChief Financial OfficerNov 04 '26Sale15.634,76974,56242,745Nov 04 05:05 PM
Ring ChristineChief Legal OfficerNov 02 '26Option Exercise8.725,78650,45421,121Nov 04 05:03 PM
Ring ChristineChief Legal OfficerNov 02 '26Sale25.8410,602273,98710,519Nov 04 05:03 PM
Ring ChristineChief Legal OfficerNov 03 '26Sale25.836,113157,9174,406Nov 04 05:03 PM
JOHANNES VAN HOUTEOfficerNov 04 '26Proposed Sale25.824,769123,136Nov 04 04:24 PM
CHRISTINE RINGOfficerNov 03 '26Proposed Sale25.706,113157,104Nov 03 04:26 PM
van Houte HansChief Financial OfficerOct 30 '26Option Exercise0.0010,182050,348Nov 02 07:47 PM
van Houte HansChief Financial OfficerOct 30 '26Sale26.282,83474,47547,514Nov 02 07:47 PM
Ring ChristineChief Legal OfficerOct 30 '26Option Exercise0.0010,182019,292Nov 02 07:44 PM
Ring ChristineChief Legal OfficerOct 30 '26Sale26.283,957103,98615,335Nov 02 07:44 PM
Hansen GwennChief Scientific OfficerNov 02 '26Option Exercise1.861,4522,701124,904Nov 02 07:42 PM
Hansen GwennChief Scientific OfficerOct 30 '26Option Exercise0.0010,1820127,409Nov 02 07:42 PM
Hansen GwennChief Scientific OfficerOct 30 '26Sale26.283,957103,986123,452Nov 02 07:42 PM
Hansen GwennChief Scientific OfficerNov 02 '26Sale26.801,45238,914123,452Nov 02 07:42 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
ARKGARK Genomic Revolution ETFAUM: 1.97B
IWMiShares Russell 2000 Index FundAUM: 77.38B
XBIState Street SPDR S&P Biotech ETFAUM: 10.50B
VXFVanguard Extended Market Index ETFAUM: 30.47B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
IBBiShares Biotechnology ETFAUM: 11.36B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
DFASU.S. Small Cap Portfolio-ETF Class SharesAUM: 15.51B
SCHASchwab U.S. Small-Cap ETFAUM: 22.25B

News

latest 14 of 100

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-10-124.730-0.6014.730673.0624.3511
2026Q22026-07-09-0.810-0.723-0.8069.0415.2915
2026Q12026-04-08-0.790-0.763-0.7926.2514.2515
2025Q42026-01-28-0.820-0.871-0.82313.5813.4017
2025Q32025-10-09-1.030-0.817-1.0277.8916.0518
2025Q22025-07-09-0.520-0.719-0.51844.0617.5517
2025Q12025-04-08-0.670-0.762-0.67418.4513.0018
2024Q42025-01-28-0.750-0.686-0.74713.2814.5517
2024Q32024-10-11-0.670-0.688-0.67312.5914.9713
2024Q22024-07-11-0.710-0.635-0.71412.0922.1112
2024Q12024-04-10-0.760-0.776-0.75616.5917.1311
2023Q42024-02-15-0.770-0.496-0.76715.1634.1412
2023Q32023-10-12-0.680-0.839-0.68018.4711.9411
2023Q22023-07-13-0.450-0.567-0.44730.6826.2411
2023Q12023-04-13-0.750-0.867-0.75412.6910.9611
2022Q42023-02-09-0.870-0.783-0.8666.7817.1710

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2020FY-2.760-2.010-2.75917.8214.04
2021FY-2.730-2.543-2.73229.7535.21
2022FY-3.710-3.546-3.71138.6347.93
2023FY-2.650-2.336-2.64976.9994.04
2024FY-2.880-2.810-2.88454.5554.58
2025FY-3.050-3.040-3.05083.9885.23
2026FY-2.352--681.8
2027FY--2.139--99.61
2028FY--0.966--244.11
2029FY--1.701--208.71
2030FY--1.156--328.13

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-10-30122337.975.0096.80
2026Q4S2026-10-18122337.955.0096.80
2026Q4S2026-10-15123337.955.0096.80
2026Q4S2026-10-13122335.875.0096.80
2026Q4S2026-10-12121027.889.0462.00
2026Q4S2026-10-04121027.889.0462.00
2026Q4S2026-09-23122027.889.0462.00
2026Q4S2026-09-04126227.889.0462.00
2026Q4S2026-08-27136226.899.0462.00
2026Q4S2026-08-19146225.689.0462.00
2026Q4S2026-08-04147225.689.0462.00
2026Q4S2026-07-21136222.899.0440.00
2026Q4S2026-07-18125222.709.0440.00
2026Q4S2026-07-17135222.229.0440.00

Estimate history

EPS, annual-0.261-0.559-2.759-2.732-3.711-2.649-2.884-3.0512.3129
Period20182019202020212022202320242025TTM
EPS, quarterly-0.673-0.747-0.674-0.518-1.027-0.823-0.792-0.8064.734
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual37.44931.11517.8229.7538.62776.98754.54983.98701.94
Period20182019202020212022202320242025TTM
Sales, quarterly12.58813.28418.45344.0567.89413.5776.2529.043673.064
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual36.15838.84538.86544.66447.17248.71975.871101.807109.2
Period20182019202020212022202320242025MRQ
Shares, quarterly67.08475.87176.23576.43476.873101.807103.4103.702109.2
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue701.9483.9854.5576.9938.6329.7517.8231.1137.45
Cost of Goods Sold Incl. D&A15.8718.8616.4313.6510.816.08---
Gross Profit686.0665.1238.1263.3327.8223.67---
Selling, General and Administrative Excl. Other396.41350.79251.15218.40211.69141.5580.6251.0044.20
Research and Development325.36308.16212.31181.62179.15113.6464.3142.6737.53
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income289.66-285.67-213.03-155.06-183.87-117.89-64.98-22.24-9.74
Interest Expense0.000.000.000.000.000.000.000.000.00
Unusual Expense0.000.000.000.000.000.000.000.000.00
Net Income Before Taxes308.21-263.70-193.30-143.95-180.36-117.06-63.78-21.46-8.92
Income Taxes13.340.760.270.000.000.13-20.540.240.51
Consolidated Net Income294.88-264.46-193.57-143.95-180.36-117.19-43.24-21.70-9.43
Net Income From Continuing Operations294.88-264.46-193.57-143.95-180.36-117.19-43.24-21.70-9.43
Net Income294.88-264.46-193.57-143.95-180.36-117.19-43.24-21.70-9.43
EPS (Recurring)2.54-3.05-2.88-2.65-3.71-2.73-2.76-0.56-0.26
EPS (Basic, Before Extraordinaries)2.51-3.05-2.88-2.65-3.71-2.73-2.76-0.56-0.26
EPS (Diluted)2.31-3.05-2.88-2.65-3.71-2.73-2.76-0.56-0.26
EBITDA305.53-266.81-196.60-141.41-173.06-111.80-62.80-19.88-6.75
Non-Operating Income (Expense)18.5521.9719.7311.123.510.821.210.780.82
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense36.0029.9926.8026.6028.1311.533.140.370.26
Price To Earnings Ratio6.876.87-------
Price To Sales Ratio4.2718.2527.214.3915.5941.5537.49--
Gross Margin97.7477.5569.8882.2672.0279.56---
Operating Margin41.27-340.16-390.52-201.41-476.01-396.26-364.66-71.46-26.01
Net Margin42.01-314.90-354.85-186.98-466.93-393.93-242.66-69.74-25.18
Shares Outstanding109.20101.8175.8748.7247.1744.6638.8638.8536.16
Market Capitalization1,734.891,734.891,566.19301.69584.161,285.741,656.021,524.69-

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue673.069.046.2513.587.8944.0618.4513.28
Cost of Goods Sold Incl. D&A3.623.853.784.635.005.104.134.30
Gross Profit669.455.192.488.952.8938.9614.328.98
Selling, General and Administrative Excl. Other110.0099.4094.9792.0494.2887.2877.1973.64
Research and Development77.1285.4081.9480.9084.0975.8567.3164.67
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income559.45-94.20-92.50-83.09-91.39-48.32-62.86-64.66
Interest Expense0.000.000.000.000.000.000.000.00
Unusual Expense0.000.000.000.000.000.000.000.00
Net Income Before Taxes563.41-89.81-87.17-78.22-86.42-42.70-56.35-58.54
Income Taxes13.61-0.270.000.000.000.760.000.01
Consolidated Net Income549.81-89.53-87.17-78.22-86.42-43.46-56.35-58.55
Net Income From Continuing Operations549.81-89.53-87.17-78.22-86.42-43.46-56.35-58.55
Net Income549.81-89.53-87.17-78.22-86.42-43.46-56.35-58.55
EPS (Recurring)4.73-0.81-0.79-0.82-1.03-0.52-0.67-0.75
EPS (Basic, Before Extraordinaries)4.93-0.81-0.79-0.82-1.03-0.52-0.67-0.75
EPS (Diluted)4.73-0.81-0.79-0.82-1.03-0.52-0.67-0.75
EBITDA563.07-90.35-88.72-78.46-86.39-43.23-58.74-60.35
Non-Operating Income (Expense)3.964.405.324.874.965.626.516.12
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense8.519.009.409.097.728.200.016.72
Price To Earnings Ratio6.87-------
Price To Sales Ratio4.2753.6624.4920.029.3910.0922.8831.78
Gross Margin99.4657.4339.6065.8936.6688.4377.6367.61
Operating Margin83.12-1,041.73-1,479.45-612.03-1,157.65-109.68-340.67-486.73
Net Margin81.69-990.10-1,394.34-576.13-1,094.77-98.66-305.38-440.75
Shares Outstanding109.20103.70103.40101.8176.8776.4376.2375.87
Market Capitalization1,734.891,836.491,642.401,792.20714.04810.381,172.451,566.19

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Cash & Short Term Investments592.94609.58287.91309.14295.72281.1537.7239.04
Short Term Receivables1.501.500.801.107.1011.350.000.00
Inventories0.000.000.000.000.000.000.000.00
Other Current Assets12.388.306.798.218.295.941.631.61
Total Current Assets606.82619.39295.50318.45311.12298.4339.3540.65
Net Property, Plant & Equipment73.0145.9047.9529.5125.346.673.874.42
Total Investments and Advances0.970.908.3264.78137.4791.060.680.17
Deferred Tax Assets14.436.098.943.303.33---
Other Assets7.343.163.824.022.830.180.150.15
Total Assets702.56675.43364.54420.06480.10396.3444.0545.40
Short Term Debt Incl. Current Port. of LT Debt2.828.017.495.533.850.000.000.00
Accounts Payable11.2111.486.405.066.653.411.601.30
Income Tax Payable1.061.240.030.090.07---
Other Current Liabilities71.3775.1273.0459.9855.6941.1314.5431.54
Total Current Liabilities86.4795.8586.9670.6666.2644.5416.1432.83
Long Term Debt52.9120.2923.126.439.190.000.000.00
Provision for Risks Charges0.000.000.000.000.000.000.000.00
Deferred Tax Liabilities14.436.098.943.303.33---
Other Liabilities10.0126.2145.0235.9759.0261.5337.431.22
Total Liabilities163.82148.44164.05116.36137.79106.0753.5734.05
Non-Equity Reserves0.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.0048.2048.20
Common Equity538.75526.99200.49303.70342.30290.27-57.71-36.85
Total Shareholders Equity538.75526.99200.49303.70342.30290.27-9.5211.35
Accumulated Minority Interest0.000.000.000.000.000.000.000.00
Total Equity538.75526.99200.49303.70342.30290.27-9.5211.35
Total Liabilities & Stockholders Equity702.56675.43364.54420.06480.10396.3444.0545.40
Book Value Per Share5.296.954.126.447.667.47-1.49-1.02
Tangible Book Value Per Share5.296.954.126.447.667.47-1.49-1.02
Full-Time Employees31728628429724213593-
Price to Book Ratio1.793.941.511.923.765.711.65-
Return on Assets-38.38-37.23-36.69-40.07-26.74-19.64-48.52-
Return on Equity-49.63-53.22-57.10-55.84-37.05-30.80-2,372.77-
Return on Invested Capital-44.70-35.37-64.37-58.16-33.34-14.90--83.08
Quick Ratio7.026.463.404.514.706.702.441.24
Current Ratio7.026.463.404.514.706.702.441.24

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income294.88-264.46-193.57-143.95-180.36-117.19-43.24-21.70-9.43
Depreciation15.8718.8616.4313.6510.816.082.182.352.99
Other Funds (Non Cash)34.5627.7322.9628.8128.7717.634.570.400.07
Funds from Operations345.31-217.87-154.18-101.49-140.78-93.48-36.49-18.94-6.37
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital34.00-31.60-18.4020.12-19.029.1136.4119.55-25.31
Cash from Operating Activities379.31-249.47-172.58-81.36-159.81-84.36-0.080.60-31.68
Capital Expenditures-9.50-14.00-9.27-8.40-12.24-5.66-4.55-1.65-1.59
Net Assets From Acquisitions0.000.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.000.01
Purchase or Sale of Investments10.60161.85-248.4476.7039.44-102.59-249.8510.1541.58
Purchase of Investments-604.34-455.69-707.95-246.33-239.37-348.50-275.22-9.35-12.92
Sale Or Maturity of Investments614.95617.54459.51323.04278.81245.9125.3719.5054.50
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities1.10147.85-257.7168.3027.20-108.25-254.408.5039.99
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock261.21238.64485.673.22117.19153.88339.020.130.53
Repurchase of Common Pref Stock0.000.00-0.010.000.00-0.00-0.01-0.02-0.00
Sale of Common Pref Stock261.21238.64485.683.22117.19153.88339.030.140.53
Proceedsfrom Stock Options255.50236.99480.632.23116.11152.22338.060.000.00
Issuance or Reduction of Debt, Net0.000.000.000.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.000.000.000.00
Cash from Financing Activities261.21238.64485.673.22117.19153.88339.020.130.53
Net Change in Cash641.62137.0355.37-9.85-15.42-38.7384.549.228.85
Free Cash Flow369.81-263.47-181.86-89.77-172.05-90.03-4.63-1.05-33.27
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow8.10--------
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments1,048.26443.53540.73592.94428.83485.78
Short Term Receivables34.101.902.401.501.7020.70
Inventories0.000.000.000.000.000.00
Other Current Assets21.3411.0511.2612.3810.078.85
Total Current Assets1,103.69456.48554.39606.82440.60515.33
Net Property, Plant & Equipment68.0470.1173.3573.0173.5368.99
Total Investments and Advances15.610.970.970.970.970.90
Deferred Tax Assets---14.43--
Other Assets7.957.987.417.347.386.34
Total Assets1,195.30535.54636.13702.56522.47591.55
Short Term Debt Incl. Current Port. of LT Debt3.243.223.202.823.795.24
Accounts Payable32.9812.2110.2911.218.615.95
Income Tax Payable13.950.251.041.060.930.91
Other Current Liabilities80.5756.3477.6771.3769.0263.52
Total Current Liabilities130.7472.0292.2086.4782.3575.61
Long Term Debt62.0954.9255.4552.9152.7046.70
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities---14.43--
Other Liabilities34.155.977.5810.0115.1821.64
Total Liabilities226.99132.91155.24163.82150.22143.95
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity968.31402.63480.89538.75372.25447.60
Total Shareholders Equity968.31402.63480.89538.75372.25447.60
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity968.31402.63480.89538.75372.25447.60
Total Liabilities & Stockholders Equity1,195.30535.54636.13702.56522.47591.55
Book Value Per Share8.873.884.655.294.845.86
Tangible Book Value Per Share8.873.884.655.294.845.86
Full-Time Employees---317--
Price to Book Ratio1.793.823.023.651.591.69
Return on Assets34.33-60.57-47.20-38.38-47.25-37.61
Return on Equity43.99-80.30-61.40-49.63-65.35-50.67
Return on Invested Capital53.36-19.57-16.25-13.22-20.34-8.79
Quick Ratio8.446.346.017.025.356.82
Current Ratio8.446.346.017.025.356.82

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income549.81-89.53-87.17-78.22-86.42-43.46
Depreciation3.623.853.784.635.005.10
Other Funds (Non Cash)9.849.837.597.317.587.68
Funds from Operations563.26-75.85-75.81-66.28-73.85-30.68
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital52.37-20.723.90-1.5516.46-32.48
Cash from Operating Activities615.63-96.57-71.91-67.83-57.38-63.16
Capital Expenditures-1.39-1.94-1.04-5.13-2.71-2.67
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments32.9794.93-122.785.4853.1974.17
Purchase of Investments-149.44-24.63-255.93-174.34-103.00-68.17
Sale Or Maturity of Investments182.42119.56133.15179.81156.19142.34
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities31.5893.00-123.830.3550.4871.50
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock5.160.0719.98236.011.160.01
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock5.160.0719.98236.011.160.01
Proceedsfrom Stock Options1.140.0019.60234.760.980.00
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities5.160.0719.98236.011.160.01
Net Change in Cash652.37-3.51-175.76168.52-5.758.34
Free Cash Flow614.24-98.51-72.96-72.96-60.10-65.84
Price to Free Cash Flow8.10-----

Revenue breakdown

Collaboration2024: 54.55M 2025: 53.98M
License2025: 30.00M
United States2024: 54.55M 2025: 83.98M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3018.20%18.9M104.1M1.71M
2026-10-1519.81%20.6M104.1M1.43M
2026-09-3017.86%17.7M98.8M1.27M
2026-09-1518.19%18.0M98.8M1.50M
2026-08-3118.16%18.0M98.8M1.99M
2026-08-1418.20%18.0M98.8M2.02M
2026-07-3118.67%18.4M98.3M2.00M
2026-07-1518.29%18.0M98.3M1.97M
2026-06-3018.18%17.8M97.9M1.98M
2026-06-1520.46%20.0M97.9M1.70M
2026-05-2919.73%19.3M97.9M1.13M
2026-05-1519.03%18.6M97.9M1.07M
2026-04-3019.72%19.2M97.4M1.07M
2026-04-1519.73%19.2M97.3M1.16M
2026-03-3118.73%18.1M96.8M1.16M
2026-03-1316.71%16.2M96.8M1.17M
2026-02-2716.50%16.0M96.8M1.39M
2026-02-1315.75%15.2M96.8M1.51M
2026-01-3014.78%15.0M101.2M1.61M
2026-01-1515.23%15.2M99.8M1.77M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call1.0013.0017.500.000.0000.000.000.996-0.0160.000
call2.0012.0016.500.000.0000.000.000.994-0.0170.000
call3.0011.0015.500.0019.3840.000.000.992-0.0180.001
call4.0010.0014.500.0014.7260.000.000.990-0.0180.001
call5.009.0013.500.0012.1190.000.000.988-0.0180.001
call6.008.0012.500.0010.3100.000.000.986-0.0180.001
call7.007.0011.500.008.9270.000.000.984-0.0180.001
call8.006.0010.500.007.8050.000.000.981-0.0170.001
call9.005.009.500.006.8570.000.000.910-0.0860.004
call10.004.008.500.006.0340.000.000.895-0.0830.005
call11.003.007.500.005.3010.000.000.877-0.0790.005
call12.002.006.500.004.6360.000.000.855-0.0740.006
call13.002.154.700.003.0151.000.000.827-0.0690.007
call14.001.353.700.002.5131.000.000.787-0.0620.007
call15.000.652.601.321.91210.000.000.683-0.0810.009
call16.000.701.201.051.0162350.000.590-0.1170.010
call17.000.051.650.451.26019.000.000.497-0.1010.010
call18.000.001.600.271.60212.000.000.397-0.0890.010
call19.000.001.550.001.8900.000.000.358-0.1020.009
call20.000.000.950.131.7481310.000.272-0.0840.008
call21.000.001.254.141.96215.000.000.252-0.0900.008
call22.000.001.203.742.15715.000.000.236-0.0960.008
call23.000.000.950.102.33632.000.000.224-0.1010.008
call24.000.001.202.602.50299.000.000.214-0.1050.007
call25.000.001.203.112.6575490.000.206-0.1090.007
call26.000.001.202.382.80272.000.000.199-0.1130.007
call27.000.001.200.102.93823.000.000.192-0.1160.007
call28.000.000.751.253.06896.000.000.187-0.1190.007
call29.000.000.500.102.05538.000.000.051-0.0310.003
call30.000.000.050.802.17210.000.000.049-0.0310.003
call31.000.001.200.751.9974.000.000.028-0.0190.002
call32.000.001.201.052.0772.000.000.028-0.0190.002
call33.000.001.201.252.1535.000.000.027-0.0190.002
call34.000.000.950.002.2260.000.000.026-0.0190.002
put1.000.000.750.009.3460.000.00-0.004-0.0160.000
put2.000.000.750.006.8520.000.00-0.006-0.0170.000
put3.000.000.750.005.5050.000.00-0.008-0.0170.001
put4.000.005.000.004.5860.000.00-0.010-0.0170.001
put5.000.005.000.003.8880.000.00-0.012-0.0170.001
put6.000.005.000.003.3250.000.00-0.014-0.0170.001
put7.000.005.000.002.8530.000.00-0.016-0.0170.001
put8.000.000.050.004.1233.000.00-0.078-0.0850.004
put9.000.005.000.003.6340.000.00-0.090-0.0850.004
put10.000.000.950.003.1310.000.00-0.105-0.0820.005
put11.000.005.000.002.6710.000.00-0.123-0.0780.005
put12.000.005.000.002.2450.000.00-0.145-0.0730.006
put13.000.001.700.001.8431010.00-0.173-0.0670.007
put14.000.000.750.001.45516.000.00-0.213-0.0600.007
put15.000.001.550.751.5232290.00-0.317-0.0790.009
put16.000.052.600.752.7839.000.00-0.410-0.1160.010
put17.000.353.301.572.8902.000.00-0.503-0.0990.010
put18.001.104.100.003.0420.000.00-0.603-0.0870.010
put19.001.704.902.003.1512.000.00-0.642-0.1000.009
put20.002.555.800.003.3240.000.00-0.728-0.0820.008
put21.003.506.801.243.5690.000.00-0.748-0.0880.008
put22.004.607.902.263.8940.000.00-0.764-0.0940.008
put23.005.308.901.964.1011.000.00-0.776-0.0980.008
put24.006.309.901.164.2930.000.00-0.786-0.1030.007
put25.007.3010.901.854.4730.000.00-0.794-0.1060.007
put26.008.3011.902.004.64121.000.00-0.801-0.1100.007
put27.009.5012.803.774.6950.000.00-0.808-0.1130.007
put28.0010.1013.900.004.9480.000.00-0.813-0.1160.007
put29.0011.1014.900.005.0890.000.00-0.949-0.0280.003
put30.0012.1015.906.155.2230.000.00-0.971-0.0150.002
put31.0013.1016.900.005.3510.000.00-0.972-0.0150.002
put32.0014.1017.900.005.4730.000.00-0.972-0.0150.002
put33.0015.1018.900.005.5900.000.00-0.973-0.0160.002
put34.0016.1019.900.005.7010.000.00-0.974-0.0160.002

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-05SCHEDULE 13G/ASEC
2026-11-04144Filing for proposed sale of securities under Rule 144.SEC
2026-11-044Statement of changes in beneficial ownership of securities2026-11-04SEC
2026-11-044Statement of changes in beneficial ownership of securities2026-11-02SEC
2026-11-03144Filing for proposed sale of securities under Rule 144.SEC
2026-11-038-KCurrent report2026-11-03SEC
2026-11-02144Filing for proposed sale of securities under Rule 144.SEC
2026-11-024Statement of changes in beneficial ownership of securities2026-10-30SEC
2026-11-024Statement of changes in beneficial ownership of securities2026-10-30SEC
2026-10-154Statement of changes in beneficial ownership of securities2026-10-15SEC
2026-10-14144Filing for proposed sale of securities under Rule 144.SEC
2026-10-144Statement of changes in beneficial ownership of securities2026-10-14SEC
2026-10-1310-QQuarterly report pursuant to Section 13 or 15(d)2026-08-31SEC
2026-10-138-KCurrent report2026-10-12SEC
2026-10-02144Filing for proposed sale of securities under Rule 144.SEC
2026-10-024Statement of changes in beneficial ownership of securities2026-10-02SEC
2026-09-23SCHEDULE 13GSEC
2026-09-02144Filing for proposed sale of securities under Rule 144.SEC
2026-09-024Statement of changes in beneficial ownership of securities2026-09-02SEC
2026-09-014Statement of changes in beneficial ownership of securities2026-09-01SEC
2026-08-14SCHEDULE 13G/ASEC
2026-08-14SCHEDULE 13G/ASEC
2026-08-14SCHEDULE 13GSEC
2026-08-14SCHEDULE 13G/ASEC
2026-08-14SCHEDULE 13GSEC
2026-08-05144Filing for proposed sale of securities under Rule 144.SEC
2026-08-054Statement of changes in beneficial ownership of securities2026-08-05SEC
2026-08-054Statement of changes in beneficial ownership of securities2026-08-04SEC
2026-08-04144Filing for proposed sale of securities under Rule 144.SEC
2026-08-04144Filing for proposed sale of securities under Rule 144.SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-1100545.38K4
2026-1000981.42K6
2026-0900186.05K2
2026-0800707.39K4
2026-0700505.80K4
2026-0600823.64K3
2026-0500461.94K3
2026-0400270.89K4
2026-0300125.79K1
2026-0200237.62K1
2026-0100284.67K4
2025-120067.31K1
2025-1100720.63K2

Institutional holders

Manager% owned
BlackRock, Inc.8.48%
Vestal Point Capital, LP7.78%
Deep Track Capital, LP7.48%
Rubric Capital Management LP6.99%
PRICE T ROWE ASSOCIATES INC /MD/5.26%
MORGAN STANLEY4.61%
STATE STREET CORP4.52%
FMR LLC4.51%
BAKER BROS. ADVISORS LP4.51%
VANGUARD CAPITAL MANAGEMENT LLC4.35%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND3.17%
iShares Russell 2000 ETF2.42%
State Street(R) SPDR(R) S&P(R) Biotech ETF2.38%
SMALLCAP World Fund Inc1.68%
ARK Genomic Revolution ETF1.62%
Eventide Healthcare & Life Sciences Fund1.26%
T. Rowe Price Health Sciences Fund, Inc.1.15%
VANGUARD EXTENDED MARKET INDEX FUND1.08%
T. Rowe Price New Horizons Fund, Inc.1.06%
Fidelity Small Cap Index Fund1.01%

OakChart. NRIX. Cached 15 minutes.